Application of mitochondrial pyruvate carrier blocker UK5099 creates metabolic reprogram and greater stem-like properties in LnCap prostate cancer cells<i>in vitro</i>Yali Zhong, Zhenhe Suo, Xiaoran Li et al.|Oncotarget|2015Cited by 79
Mitochondrial pyruvate carrier function determines cell stemness and metabolic reprogramming in cancer cellsXiaoli Li, Zhenhe Suo, Yaqing Li et al.|Oncotarget|2017Cited by 69
MtDNA depleted PC3 cells exhibit Warburg effect and cancer stem cell featuresXiaoran Li, Zhenhe Suo|Oncotarget|2016Cited by 51
MPC1 and MPC2 expressions are associated with favorable clinical outcomes in prostate cancerXiaoli Li, Zhenhe Suo, Yasai Ji et al.|BMC Cancer|2016Cited by 48
ILs-3, 6 and 11 increase, but ILs-10 and 24 decrease stemness of human prostate cancer cells <i>in vitro</i>Dandan Yu, Zhenhe Suo, Yali Zhong et al.|Oncotarget|2015Cited by 24